Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

BACKGROUND: Neoadjuvant aromatase inhibitor therapy has been reported to improve surgical outcomes for postmenopausal women with clinical stage II or III hormone receptor-positive breast cancer. A multicenter phase II clinical trial was conducted to investigate the value of this approach for US surg...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Olson, John A, Budd, G Thomas, Carey, Lisa A, Harris, Lyndsay A, Esserman, Laura J, Fleming, Gini F, Marcom, Paul K, Leight, George S, Giuntoli, Therese, Commean, Paul, Bae, Kyongtae, Luo, Jingqin, Ellis, Matthew J
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3683862/
https://ncbi.nlm.nih.gov/pubmed/19476859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2009.01.035
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы